to assess the efficacy and safety of intravenous diltiazem , 54 patients with inducible sustained supraventricular tachycardia received diltiazem , 0.25 mg/kg or 0.25 mg/kg , followed by 0.35 mg/kg body weight , or placebo in a double-blind , randomized study .
C0039240
supraventricular tachycardia
C0012373
diltiazem